Adipotide 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Adipotide supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF112025072

Key analytical results include:

• Assay Content: 10.38 mg
• Identification – Retention Time: 0.998
• Identification – Spectrum: 994
• Purity: 99.5 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Adipotide is a synthetic peptide research compound commonly studied in controlled laboratory environments investigating cellular signalling pathways associated with adipose tissue and metabolic regulation.

The compound belongs to a class of targeted peptides designed to interact with specific cellular receptors expressed on adipose tissue vasculature.

This preparation contains 10 mg of high purity lyophilized compound supplied in a sealed research vial. The lyophilization process preserves molecular stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, Adipotide has been referenced in experimental research models exploring peptide-mediated cellular targeting mechanisms.

Compound Overview

Adipotide is a synthetic peptide engineered to interact with receptors expressed in adipose tissue-associated vasculature.

In biochemical research models, the compound has been studied for its interaction with molecular pathways associated with adipocyte regulation and cellular signalling systems.

Peptide-based molecules such as Adipotide are frequently used in experimental research to investigate receptor targeting, peptide signalling behaviour and molecular regulatory mechanisms.

Its defined peptide structure allows researchers to explore receptor-binding dynamics and peptide-mediated signalling responses in controlled laboratory conditions.

Historical Background and Scientific Context

Scientific interest in targeted peptide therapeutics and molecular signalling research expanded significantly during the late twentieth century with advances in peptide synthesis and molecular biology.

During the early 2000s researchers began investigating peptides capable of selectively interacting with vascular markers associated with adipose tissue.

This work led to the development of experimental peptides designed to target specific cellular receptors within adipose-associated vascular networks.

Adipotide emerged from this field of research as a compound used to explore peptide targeting strategies and signalling pathways involved in adipose tissue biology.

Since its introduction in experimental research, the compound has been utilised in laboratory models studying receptor targeting and metabolic signalling interactions.

Mechanistic Focus in Research

Within experimental laboratory environments, Adipotide is commonly studied in relation to peptide-mediated targeting mechanisms and adipose-associated signalling pathways.

Research investigations frequently explore the compound in experimental models examining:

• Peptide targeting of adipose-associated receptors
• Adipose tissue vascular signalling pathways
• Cellular metabolic regulation networks
• Peptide-receptor binding dynamics
• Intracellular signalling cascade modelling
• Comparative peptide targeting studies
• Molecular interaction systems within metabolic tissues

These experimental models enable researchers to analyse molecular signalling mechanisms involved in adipose tissue regulation and peptide-target interaction systems.

Research Applications

In controlled research environments, Adipotide may be utilised in experimental models designed to explore adipose-related signalling systems and peptide targeting strategies.

Examples of research applications include:

• Adipose tissue signalling research
• Peptide receptor targeting studies
• Metabolic pathway investigation
• Molecular signalling network modelling
• Comparative peptide compound evaluation
• Experimental metabolic regulation studies
• Controlled in vitro peptide interaction research

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 10.38 mg
Confirmed purity 99.5 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.